Teva | Israel news feed

Amalia Adler-Waxman, Senior Vice President, Global Head of Sustainability and Head of Corporate Affairs of International Markets at Teva, spoke at the Jerusalem Post's Women Leaders Summit.

The funding agreement will offset program costs for Teva, which will lead the clinical development of the schizophrenia treatment and regulatory process and is responsible for commercialization.

Biolojic is eligible to receive tiered royalties in "mid-single to low-double digit" millions of dollars on product sales should Teva successfully commercialize a therapy.

Teva has outshone ICL, Check Point and Mobileye in terms of revenue and profit but not profitability.

At the end of 2023, Israeli insurance and finance group The Phoenix Holdings' stake in Teva was 5.4%.